Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Non-Current Liabilities: 2023-2025

Historic Total Non-Current Liabilities for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $11.0 million.

  • Camp4 Therapeutics' Total Non-Current Liabilities fell 39.55% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 39.55%. This contributed to the annual value of $15.2 million for FY2024, which is 8.27% down from last year.
  • Camp4 Therapeutics' Total Non-Current Liabilities amounted to $11.0 million in Q3 2025, which was down 2.57% from $11.3 million recorded in Q2 2025.
  • Camp4 Therapeutics' Total Non-Current Liabilities' 5-year high stood at $18.2 million during Q3 2024, with a 5-year trough of $11.0 million in Q3 2025.
  • In the last 3 years, Camp4 Therapeutics' Total Non-Current Liabilities had a median value of $13.2 million in 2024 and averaged $13.9 million.
  • Data for Camp4 Therapeutics' Total Non-Current Liabilities shows a maximum YoY crashed of 39.55% (in 2025) over the last 5 years.
  • Camp4 Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $16.5 million in 2023, then decreased by 8.27% to $15.2 million in 2024, then tumbled by 39.55% to $11.0 million in 2025.
  • Its Total Non-Current Liabilities was $11.0 million in Q3 2025, compared to $11.3 million in Q2 2025 and $11.2 million in Q1 2025.